Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Glycosylated haemoglobin increased? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Glycosylated haemoglobin increased have been filed in association with RIBOCICLIB (KISQALI). This represents 0.1% of all adverse event reports for RIBOCICLIB.

20
Reports of Glycosylated haemoglobin increased with RIBOCICLIB
0.1%
of all RIBOCICLIB reports
2
Deaths
7
Hospitalizations

How Dangerous Is Glycosylated haemoglobin increased From RIBOCICLIB?

Of the 20 reports, 2 (10.0%) resulted in death, 7 (35.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.

Is Glycosylated haemoglobin increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Glycosylated haemoglobin increased?

DULAGLUTIDE (2,691) INSULIN GLARGINE (2,649) INSULIN LISPRO (2,482) METFORMIN (1,539) INSULIN HUMAN (1,008) EXENATIDE (921) SEMAGLUTIDE (818) EMPAGLIFLOZIN (743) TIRZEPATIDE (555) INSULIN ASPART (550)

Which RIBOCICLIB Alternatives Have Lower Glycosylated haemoglobin increased Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Glycosylated haemoglobin increased Reports All Drugs Causing Glycosylated haemoglobin increased RIBOCICLIB Demographics